8 May 2018 Tablets & Capsules
C
ounterfeit drug products and their potentially fatal
outcomes are in the news nearly every week. The market
for counterfeit versions of drug products such as potency
pills and heparin is booming and can have higher profit
margins than the cocaine trade. For consumers, it's often
nearly impossible to detect whether a product is genuine
or counterfeit. Numerous laws and guidelines have
already been enacted or will soon come into effect
around the world to protect consumers from these
threats.
This article discusses the challenges pharmaceutical companies
face in complying with drug anti-counterfeiting regulations
around the world and describes a holistic approach to tackling
those challenges.
From serialization to aggregation:
A holistic approach
Jörg Willburger
Bosch Packaging Technology
packaging
